CER Has Been A Part Of CMS Coverage Decisions In Recent Years – Avalere
This article was originally published in The Gray Sheet
During the health care reform debate, much concern was expressed that results of comparative effectiveness research from the Patient-Centered Outcomes Research Institute could play a key role in Medicare coverage decisions.
You may also be interested in...
Under an April 25 proposal, pacemaker patients not enrolled in a clinical trial would be eligible for Medicare-reimbursed magnetic resonance imaging scans, under certain conditions, if their implant is FDA-approved for use in the MRI environment.
CMS has finalized a proposal from last year to cover magnetic resonance imaging scans of patients with pacemaker and defibrillator implants, but only in certain well-controlled studies, while maintaining its MRI coverage restriction for patients with the implants in all other contexts.
Despite barriers built into the health reform law to prevent use of comparative cost analyses to set Medicare reimbursement rates, allowing such analyses could enable billions in savings, according to an article in the October issue of Health Affairs